Active Ingredient History

  • Now
Dapivirine is a non-nucleoside reverse transcriptase inhibitor developed at Janssen Therapeutics. The International Partnership for Microbicides has held exclusive worldwide rights to dapivirine since 2014, building upon a 2004 royalty-free license to develop dapivirine-based microbicides for women in resource-poor countries.   Wikipedia

  • SMILES: Cc1cc(C)c(Nc2ccnc(Nc3ccc(cc3)C#N)n2)c(C)c1
  • Mol. Mass: 329.41
  • ALogP: 4.76
  • ChEMBL Molecule:
More Chemistry
aids-105293 | dapivirine | r-147681 | tmc120 | tmc-120 | tmc120-r147681


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue